121 related articles for article (PubMed ID: 26392778)
41. The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.
LeBlanc ME; Wang W; Chen X; Ji Y; Shakya A; Shen C; Zhang C; Gonzalez V; Brewer M; Ma JX; Wen R; Zhang F; Li W
Mol Vis; 2016; 22():374-86. PubMed ID: 27122967
[TBL] [Abstract][Full Text] [Related]
42. Hepatoma-derived growth factor: from the bovine uterus to the in vitro embryo culture.
Gómez E; Correia-Álvarez E; Caamaño JN; Díez C; Carrocera S; Peynot N; Martín D; Giraud-Delville C; Duranthon V; Sandra O; Muñoz M
Reproduction; 2014 Oct; 148(4):353-65. PubMed ID: 25009202
[TBL] [Abstract][Full Text] [Related]
43. Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.
Guo Z; He Y; Wang S; Zhang A; Zhao P; Gao C; Cao B
Oncol Rep; 2011 Aug; 26(2):511-7. PubMed ID: 21567096
[TBL] [Abstract][Full Text] [Related]
44. p53 negatively regulates the hepatoma growth factor HDGF.
Sasaki Y; Negishi H; Idogawa M; Yokota I; Koyama R; Kusano M; Suzuki H; Fujita M; Maruyama R; Toyota M; Saito T; Tokino T
Cancer Res; 2011 Nov; 71(22):7038-47. PubMed ID: 22006999
[TBL] [Abstract][Full Text] [Related]
45. shRNA targeting HDGF suppressed cell growth and invasion of squamous cell lung cancer.
Meng J; Xie W; Cao L; Hu C; Zhe Z
Acta Biochim Biophys Sin (Shanghai); 2010 Jan; 42(1):52-7. PubMed ID: 20043047
[TBL] [Abstract][Full Text] [Related]
46. Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.
Li GW; Yan X
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1915-1925. PubMed ID: 30915734
[TBL] [Abstract][Full Text] [Related]
47. HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.
Jiang H; Fu Q; Song X; Ge C; Li R; Li Z; Zeng B; Li C; Wang Y; Xue Y; Luo R; Fang W
Oncol Lett; 2019 Nov; 18(5):4936-4946. PubMed ID: 31612005
[TBL] [Abstract][Full Text] [Related]
48. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
49. Hepatocarcinoma cell-derived hepatoma-derived growth factor (HDGF) induces regulatory T cells.
Sun AM; Li CG; Zhang YQ; Lin SM; Niu HR; Shi YS
Cytokine; 2015 Mar; 72(1):31-5. PubMed ID: 25569374
[TBL] [Abstract][Full Text] [Related]
50. Helicobacter pylori Infection-Induced Hepatoma-Derived Growth Factor Regulates the Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells.
Liu CJ; Wang YK; Kuo FC; Hsu WH; Yu FJ; Hsieh S; Tai MH; Wu DC; Kuo CH
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30513684
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells.
Liu Y; Sun J; Yang G; Liu Z; Guo S; Zhao R; Xu K; Wu X; Zhang Z
Mol Med Rep; 2015 Sep; 12(3):4713-4719. PubMed ID: 26081074
[TBL] [Abstract][Full Text] [Related]
52. FGF5 promotes osteosarcoma cells proliferation via activating MAPK signaling pathway.
Han D; Wang M; Yu Z; Yin L; Liu C; Wang J; Liu Y; Jiang S; Ren Z; Yin J
Cancer Manag Res; 2019; 11():6457-6466. PubMed ID: 31372048
[No Abstract] [Full Text] [Related]
53. Hepatoma-derived growth factor is induced in liver regeneration.
Enomoto H; Nakamura H; Liu W; Yoshida K; Okuda Y; Imanishi H; Saito M; Shimomura S; Hada T; Nishiguchi S
Hepatol Res; 2009 Oct; 39(10):988-97. PubMed ID: 19624773
[TBL] [Abstract][Full Text] [Related]
54. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
55. Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival.
Yang J; Ambade AS; Nies M; Griffiths M; Damico R; Vaidya D; Brandal S; Pauciulo MW; Lutz KA; Coleman AW; Nichols WC; Austin ED; Ivy D; Hassoun PM; Everett AD
Pulm Circ; 2022 Jan; 12(1):e12007. PubMed ID: 35506100
[TBL] [Abstract][Full Text] [Related]
56. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.
Enomoto H; Yoshida K; Kishima Y; Kinoshita T; Yamamoto M; Everett AD; Miyajima A; Nakamura H
Hepatology; 2002 Dec; 36(6):1519-27. PubMed ID: 12447878
[TBL] [Abstract][Full Text] [Related]
57. cPLA
Pang X; Yin P; Han J; Wang Z; Zheng F; Chen X
Pathol Res Pract; 2019 Jun; 215(6):152398. PubMed ID: 31003849
[TBL] [Abstract][Full Text] [Related]
58. Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration.
Narron JV; Stoops TD; Barringhaus K; Matsumura M; Everett AD
Pediatr Res; 2006 Jun; 59(6):778-83. PubMed ID: 16641209
[TBL] [Abstract][Full Text] [Related]
59. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.
Wang Y; Wang N; Zeng X; Sun J; Wang G; Xu H; Zhao W
Oncol Lett; 2017 May; 13(5):3057-3065. PubMed ID: 28521412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
